COLUMBIA, SC – October. 8, 2024 – To meet a need for demanding company roles, The Ritedose Corporation (Ritedose) partnered with inSpring and Benedict College to develop RISE, a workforce initiative for international STEM students at the Historically Black College and University (HBCU).
September 17, 2024 — The Ritedose Corporation, Inc. (Ritedose), the largest CDMO in the United States specializing in sterile Blow Fill Seal (BFS) production of unit dose solutions for the ophthalmic and respiratory markets, is proud to partner with Verona Pharma plc (Nasdaq: VRNA) as the development and manufacturing partner of Ohtuvayre, a new novel product for Chronic Obstructive Pulmonary Disease (COPD).
COLUMBIA, S.C., August 12, 2024 – Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces today that it will donate 1 Million (1M) doses to the national charitable medication distributor, Dispensary of Hope, to provide essential respiratory medications for low-income and chronically ill patients across the country.
COLUMBIA, S.C. July 29, 2024 – Working together, The Ritedose Corporation (Ritedose) employees raised more than $77,000 during the company’s annual Field Day event this spring in support of the American Heart Association. Additionally, the Association recognized Ritedose as the #1 Field Day company in the nation for 2023.
COLUMBIA, S.C., July 12, 2024 – Eight interns from The Ritedose Corporation (Ritedose) volunteered at the Harvest Hope, South Carolina’s largest food distribution charity this month—packaging boxes of food for needy families on July 10. The humanitarian work was part of the Ritedose summer internship program, where student-employees volunteer for a day of community service.
COLUMBIA, S.C. June 20, 2024 – The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces a significant expansion of its production capabilities to meet the demand for ophthalmic and respiratory medications.
Columbia, S.C. (February 22, 2024) — The Ritedose Corporation (Ritedose) today announced a major expansion of its rapidly-growing pharmaceutical company with the recent purchase of 105 acres from the Midlands Technical College Enterprise Campus in Richland Northeast.
COLUMBIA, S.C. (August 24, 2023) – Ritedose, a pharmaceutical manufacturer located in South Carolina, launched a new sterile unit dose generic product, Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml). The single-dose vial product joins a range of other inhalation solutions produced by Ritedose Pharmaceuticals and is available in cartons of 60 vials. Ritedose Pharmaceuticals is a division of The Ritedose Corporation, a 27-year-leader in cGMP drug manufacturing for major pharmaceutical companies, research development programs, hospitals, wholesalers and pharmacies.
COLUMBIA, S.C. (May 9, 2023) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose vial product, Albuterol Sulfate Inhalation Solution 0.5% (5 mg/mL). It is a ready-to-use drug shortage solution for hospital pharmacies across the country. Ritedose is a division of The Ritedose Corporation, a 27-year-leader in cGMP drug manufacturing for major pharmaceutical companies and research development programs.